C Rebouissou
Overview
Explore the profile of C Rebouissou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dardalhon V, Jaleco S, Rebouissou C, Ferrand C, Skander N, Swainson L, et al.
Blood
. 2000 Jul;
96(3):885-93.
PMID: 10910901
Retroviral vectors based on the Moloney murine leukemia virus (MuLV) have become the primary tool for gene delivery into hematopoietic cells, but clinical trials have been hampered by low transduction...
2.
Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, et al.
J Biol Chem
. 2000 Apr;
275(21):15832-8.
PMID: 10748099
ZAP-70-deficient patients present with nonfunctional CD4+ T cells in the periphery. We find that a subset of primary ZAP-70-deficient T cells, expressing high levels of the related protein-tyrosine kinase Syk,...
3.
Gu Z, De Vos J, Rebouissou C, Jourdan M, Zhang X, Rossi J, et al.
Leukemia
. 2000 Jan;
14(1):188-97.
PMID: 10637495
We have previously reported obtaining two monoclonal antibodies (mAb) against the human gp130 interleukin-6 (IL-6) transducer which made possible the dimerization of gp130 and the activation of several IL-6-driven functions...
4.
Dardalhon V, Noraz N, Pollok K, Rebouissou C, Boyer M, Bakker A, et al.
Hum Gene Ther
. 1999 Feb;
10(1):5-14.
PMID: 10022526
The success of gene therapy strategies for congenital and acquired blood disorders requires high levels of gene transfer into hematopoietic cells. Retroviral vectors have been extensively used to deliver foreign...
5.
Rebouissou C, Wijdenes J, Autissier P, Tarte K, Costes V, Liautard J, et al.
Blood
. 1998 Jun;
91(12):4727-37.
PMID: 9616171
Agonist antihuman gp130 transducer monoclonal antibodies (MoAbs) were used in SCID mice to grow myeloma cells whose survival and proliferation is dependent on gp130 transducer activation. The agonist anti-gp130 MoAbs...
6.
Zhang X, Olive D, Devos J, Rebouissou C, Ferlin M, Klein B
Leukemia
. 1998 Apr;
12(4):610-8.
PMID: 9557621
The function of CD28 molecules that are present on malignant plasma cells of human myeloma cell lines (HMCL) was studied. First, myeloma cells expressed a similar density of CD28 antigen...
7.
Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules
Tissot C, Rebouissou C, Klein B, Mechti N
J Interferon Cytokine Res
. 1997 Jan;
17(1):17-26.
PMID: 9041467
We have established a cDNA library from interferon (IFN)-treated human lymphoblastoid Daudi cells and made use of differential screening to search for yet unidentified IFN-regulated genes. In the course of...
8.
Lemasson I, Briant L, Hague B, Coudronniere N, Heron L, David C, et al.
J Immunol
. 1996 Jan;
156(2):859-65.
PMID: 8543843
mAbs that bind to the Ig CDR3-like region in D1 domain of the CD4 molecule can inhibit the HIV-1 life cycle in CD4-positive T cells and lymphoblastoid cell lines at...